Open-label, randomized multicenter phase II clinical trial of a toll-like receptor-2 (TLR2) agonist mycobacterium w (Cadi-05) in combination with paclitaxel plus cisplatin versus paclitaxel plus cisplatin in advanced non-small cell lung cancer (NSCLC).
Authors:
- C. P. BelaniCBC. P. Belani
- D. DesaiDDD. Desai
- B. M. KhamarBKB. M. Khamar
- for the Cadi-05 Investigators Study GroupFGfor the Cadi-05 Investigators Study Group
- 20 May 2011
- journal article
- other
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 29 (15_suppl) , 7501